Loading...

TSBX TURNSTONE BIOLOGICS CORP Earnings Reports 8-K Filing

TRNS

TSBX

TURNSTONE BIOLOGICS CORP

(TSBX)

2024 8-K

Show Summary

Show Summary

Financial Statements

Stock Delisting

Financial Results

Strategic Alternatives

Workforce Reduction

Nasdaq Compliance Notice

Financial Results

Annual Meeting Results

Financial Results Announcement

Departure of Directors

Earnings Reports

Regulation FD Disclosure

Initial Public Offerings

External Links:

Turnstone Biologics Corp. announced its financial results for Q2 2024 and positive initial data from its Phase 1 trial of TIDAL-01 for metastatic colorectal cancer on August 14, 2024.

AI Assistant

TURNSTONE BIOLOGICS CORP

2024

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.